Navin Fluorine International (532504) Q3 24/25 earnings summary

Executive summary

• Achieved strong revenue and profit growth in Q3 FY25 and 9M FY25, driven by robust performance across business segments and key milestones like commissioning the agro-specialty plant at Dahej.

• Demonstrated resilience amid global macro and geopolitical uncertainties, focusing on operational adaptability and customer relationships.

• Dewas site awarded EcoVadis gold medal for sustainability practices, placing among top 5% globally.

• Unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024, were approved and reviewed by the Board and Audit Committee.

• Interim dividend of ₹5 per share (250%) paid during the quarter, totaling ₹24.79 crores.

Financial highlights

• Q3 FY25 consolidated revenue at ₹606.20 crores, up 21% year-on-year and 17% quarter-on-quarter; operating EBITDA at ₹147.3 crores, up 95% year-on-year, with margin at 24.3%.

• Profit after tax for Q3 FY25 at ₹83.60 crores; nine-month FY25 revenue at ₹1,648.4 crores, up 13% year-on-year; nine-month EBITDA at ₹355 crores, up 23%.

• Operating PBT for Q3 FY25 was ₹97.5 crores, up 195% year-on-year.

• Exceptional gain of ₹52.13 crores in Q3 & 9M FY24 from sale of surplus land.

• Net debt to equity at 0.41; net working capital days at 99.

Outlook and guidance

• Strong order visibility for Q4 FY25 and into FY26 across specialty chemicals and CDMO segments.

• No upgrade to margin guidance; aim to exit FY25 near 25% EBITDA margin, focusing on sustainability.

• R32 capacity expansion to be commissioned by February 2025; further strategic expansion under discussion.

• Project Nectar to ramp up gradually, targeting full ramp by FY27.

• The company continues to focus on its core chemical business and maintains a single reportable segment.